Company
» Management
» Board of Directors
» Scientific Advisory Board
» Investors
» Careers
Science
» Neurotrophic Factors
» Gene Delivery Technology
» Alzheimer's Disease
» Parkinson's Disease
» ALS
» Ocular Diseases
Pipeline
» Clinical Trials
Investors
» Company Fact Sheet
» Business Development
Newsroom
» Press Releases
» Articles
Contact
Home
|
Site Map
|
Contact
|
Directions
Newsroom
2004 Press Releases
08.04.04
Ceregene Announces $32 Million Series B Financing
04.29.04
Ceregene Confirms Plans to Further Develop Alzheimer's Disease Gene Therapy
02.11.04
Ceregene Announces Issuance of Broad Patent for Neurologic Gene Therapy
Archived Press Releases:
2006
|
2005
|
2004
|
2003
|
2002
|
2001